CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Surgical management and role of imatinib therapy in giant gist: a single-based cancer center series

Author: 
Heba Gamal El-DIN, Eman Naguib Khorsheid and Marwa Mahmoud Selim
Subject Area: 
Health Sciences
Abstract: 

Introduction: Gastrointestinal stromal tumors (GIST) represent 3% of all GIT tumors (Lech, Korcz et al., 2015) and 85% of all mesenchymal tumors of the gastrointestinal tract (GIT), their biological behavior ranges from borderline to malignant depending on the size and the mitotic activity, tumor site, tumor vascularization and infiltration (Lech, Korcz et al. 2015). Patients and methods: This is a retrospective observational study comprising 90 cases of Giant GIST in the National Cancer Institute during the period from 2010 to 2020. Results: All the giant GIST patients underwent surgical resection, including 77 cases (91.7%) of R0 resection, 5 cases (5.9%) of R1 resection and 2 cases (2.4%) of R2 resection, besides, 16 cases (19.2%) underwent multiorgan resection and 24 cases (28.6) underwent lymphadenectomy. Discussion: To our knowledge this is one of the largest series of published Giant GIST. Many case reports of giant rare subtypes of GISTS were published. The incidence of the large size of the tumors in this study is 40.4% which is high compared to the published data estimating that only 20% of GIST tumors present as giant GIST., this is because most of the GIST are diagnosed after reaching very large sizes causing symptoms(Kimura, Togawa et al. 2020). Conclusion: Complete surgical excision combined with targeted therapy imatinib can improve the prognosis significantly whether used in the neoadjuvant setting to downsize the tumor or in the adjuvant setting to decrease recurrences. Overall survival and DFS in this study are excellent and comparable to the literature

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran